Brexpiprazole Impurity 7 CAS 913613-82-8
| CAS No. | 913613-82-8 |
| Molecular Formula | C13H14ClNO2 |
| Molecular Weight | 251.71 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Owing to a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution, Brexpiprazole Impurity 7 is typically off-white to pale yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 251.71 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
CATO supplies Brexpiprazole Impurity 7 (CAS 913613-82-8), a pharmacopoeial impurity reference standard (molecular formula C13H14ClNO2, MW 251.71 g/mol) used for the identification and quantification of trace impurities in APIs.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Brexpiprazole Impurity 7 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C13H14ClNO2 |
| Molecular Weight | 251.71 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 7.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1987 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Brexpiprazole Standards
- Brexpiprazole Impurity 16 (CAS 2116542-22-2)
- Brexpiprazole Impurity 161 (CAS CATO-C4X-1131161)
- Brexpiprazole Impurity 23 (CAS CATO-C4X-113123)
- Brexpiprazole Impurity 24 (CAS 2809183-06-8)
- Brexpiprazole Impurity 13 (CAS 15116-41-3)
- Brexpiprazole Impurity 66 (CAS CATO-C4X-113166)
- Brexpiprazole Impurity 87 (CAS 62969-59-9)
- Brexpiprazole Impurity 54 (CAS CATO-C4X-113154)
Recommended Standards
- Domperidone EP Impurity A (CAS 53786-28-0)
- Lornoxicam Impurity 31 (CAS CATO-C4X-201631)
- Pyrimethamine EP Impurity D (CAS 55474-41-4)
- N-(1-(tert-Butyl)-1H-pyrazol-5-yl)-6-chloropyrazin-2-amine (CAS 1010086-61-9)
- Ivacaftor Impurity 14 (CAS 54535-22-7)
- Letermovir Impurity 75 (CAS CATO-C4X-291575)
- Cefotiam Impurity 34 (CAS CATO-C4X-120434)
- 2-(3-Bromophenyl)-4-methyl-1H-imidazole-5-carboxylic acid (CAS 1226336-64-6)
- 2-Oxa-9-azaspiro[5.5]undecane (CAS 374795-48-9)
- Eravacycline Impurity 5(TP-6773） (CAS CATO-C4X-29385)
- N-((1-(3,4-Dimethylphenyl)-1H-tetrazol-5-yl)methyl)-3-methylbutanamide (CAS 920432-00-4)
- (3-Bromo-5-fluoropyridin-2-yl)methanamine (CAS 1211531-47-3)
- 4-Ethoxybenzo[d]oxazole-2-sulfonyl chloride (CAS 1807095-67-5)
- Semaglutide impurity 75 (CAS CATO-C4X-222675)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com